Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapy
Main Authors: | Wang, Zhi-Yu, Chen, Meng, Zhu, Ling-Ling, Yu, Lu-Shan, Zeng, Su, Xiang, Mei-Xiang, Zhou, Quan |
---|---|
Format: | Online |
Language: | English |
Published: |
Dove Medical Press
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373598/ |
Similar Items
-
Pharmacokinetic drug interaction profile of omeprazole with adverse consequences and clinical risk management
by: Li, Wei, et al.
Published: (2013) -
Pharmacokinetic drug–drug interactions between 1,4-dihydropyridine calcium channel blockers and statins: factors determining interaction strength and relevant clinical risk management
by: Zhou, Yi-Ting, et al.
Published: (2013) -
The use of oral suspension and rationally prescribing alternatives may be supplemental to the implementation of clopidogrel new algorithm comprising CYP2C19 pharmacogenetics and drug interactions
by: Chen, Meng, et al.
Published: (2016) -
The Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel in Healthy Japanese Volunteers
by: Umemura, Kazuo, et al.
Published: (2016) -
Is it appropriate regarding patient preference to take Myrtol standardized enteric-coated soft capsules after a meal rather than at fasted state? A food–drug pharmacokinetic interaction study in healthy Chinese volunteers
by: Zhao, Ting-Ting, et al.
Published: (2016)